Merritt; Leander
Patent Applications and Registrations
Patent applications and USPTO patent grants for Merritt; Leander.The latest application filed is for "aromatic ether derivatives useful as thrombin inhibitors".
- Merritt; Leander - Indianapolis IN
| Patent | Date |
|---|---|
| Aromatic ether derivatives useful as thrombin inhibitors Grant 7,700,628 - Argade , et al. April 20, 2 | 2010-04-20 |
| Antithrombotic ethers Grant 7,615,568 - Franciskovich , et al. November 10, 2 | 2009-11-10 |
| Aromatic Ether Derivatives Useful As Thrombin Inhibitors App 20090227566 - Argade; Ankush Baburao ; et al. | 2009-09-10 |
| Antithrombotic aromatic ethers Grant 7,511,066 - Franciskovich , et al. March 31, 2 | 2009-03-31 |
| Antithrombotic Ethers App 20080108594 - Franciskovich; Jeffry Bernard ; et al. | 2008-05-08 |
| Antithrombotic aromatic ethers App 20070027185 - Franciskovich; Jeffry Bernard ; et al. | 2007-02-01 |
| Heterocyclic compounds Grant 6,117,883 - Merritt , et al. September 12, 2 | 2000-09-12 |
| Process for preparing 1,2,5-thiadiazole containing ethers Grant 6,040,442 - Merritt , et al. March 21, 2 | 2000-03-21 |
| Heterocyclic compounds and their preparation and use Grant 5,672,709 - Alt , et al. September 30, 1 | 1997-09-30 |
| Heterocyclic compounds and their preparation and use Grant 5,665,745 - Alt , et al. September 9, 1 | 1997-09-09 |
| Heterocyclic compounds and their preparation and use Grant 5,646,289 - Alt , et al. July 8, 1 | 1997-07-08 |
| Heterocyclic compounds and their use Grant 5,605,908 - Merritt , et al. February 25, 1 | 1997-02-25 |
| Optionally substituted (3.beta.-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement Grant 4,798,834 - Merritt , et al. January 17, 1 | 1989-01-17 |
| 3-(Imidazol-4-yl)-2-phenylpropanenitriles Grant 4,281,141 - Merritt , et al. July 28, 1 | 1981-07-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 